Pulmonic valve regurgitation occurs when blood leaks abnormally backward from the pulmonary artery through the pulmonic valve into the right ventricle. This can result in right heart failure. Pulmonic ...
The FDA gave the greenlight to transcatheter pulmonic valve replacement with the Sapien 3 system plus an adaptive pre-stent landing zone, dubbed Alterra, for patients with congenital heart disease.
Please provide your email address to receive an email when new articles are posted on . New data published in Chest support a lower tricuspid regurgitation velocity of 2.7 m per second for pulmonary ...
The US Food and Drug Administration has approved the Harmony transcatheter pulmonary valve (TPV) system (Medtronic) as the first nonsurgical heart valve to treat pulmonary-valve regurgitation in ...
Edwards Lifesciences is closing out 2021 by nabbing a new approval from FDA. The Irvine, CA-based company said it won the nod for the use of the Edwards Sapien 3 transcatheter valve with the Alterra ...
For years, innovations in the treatment of pulmonary valve regurgitation have relied on invasive surgical treatments—until now. A device from Medtronic that takes a minimally invasive approach to ...
During embryonic development, the right ventricle is formed from the secondary heart field into a crescent-shaped, thin-walled structure. 6 It is the most anterior heart chamber, sitting just beneath ...
The US Food and Drug Administration (FDA) has cleared Edwards Lifesciences’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement, the manufacturer ...
Ronald H. Wharton, MD: Greetings. This is Ronald Wharton. I am a cardiologist at Montefiore Medical Center, Bronx, New York, and assistant professor of medicine at the Albert Einstein College of ...
Adults with congenital heart disease who have pulmonary hypertension may have dissection of the pulmonary artery. Increasingly recognized as a lethal complication, pulmonary-artery dissection has ...
Biventricular correction of tetralogy of Fallot was devised more than 50 years ago. Current short-term outcomes are excellent. The potential for late complications is, however, an important concern ...